RXST
RxSight, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$4.99
+8.71%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$4.11
From 52W high−61.88%
Volume2.75M
Market cap$209.23M
P/E (TTM)—
P/S (TTM)1.7x
Div yield—
Key dataNov 4, 2026
Open
$4.11
From 52W high
−61.88%
Volume
2.75M
Market cap
$209.23M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.7x
P/E (TTM)
—
RSI (14)
57.8
MomentumView details →
1D Return
+8.71%
YTD Return
−49.33%
SummaryUpdated Sep 1, 2026
RxSight, Inc. (NASDAQ:RXST) is a medical technology company founded in 1997 and headquartered in Aliso Viejo, California. Originally incorporated as Calhoun Vision, Inc., the company changed its name to RxSight in February 2017 and went public in July 2021. RxSight has developed and commercialized the world's first and only adjustable intraocular lens technology for cataract surgery, allowing surgeons to customize patients' vision after the initial surgical procedure. The company primarily serves the United States market with plans for international expansion into Europe and Asia.
Similar companies
Latest newsMore news →
RxSight, Inc. reported financial results for the quarter ended September 30, 2026.1d agoRxSight granted inducement stock options covering 236,456 common shares to two new non-executive employees and agreed to grant them inducement RSUs covering 637,449 shares.12d agoRxSight granted inducement stock options and restricted stock units to its new President and CEO Aziz Mottiwala in connection with his commencement of employment.101d ago